Your browser doesn't support javascript.
loading
New insights on the interaction mechanism of rhTNFα with its antagonists Adalimumab and Etanercept.
Contreras, María Angélica; Macaya, Luis; Neira, Pedro; Camacho, Frank; González, Alaín; Acosta, Jannel; Montesino, Raquel; Toledo, Jorge Roberto; Sánchez, Oliberto.
  • Contreras MA; Recombinant Biopharmaceuticals Laboratory, Pharmacology Department, School of Biological Sciences, Universidad de Concepción, Victor Lamas 1290, PO Box 160-C, Concepción, Chile.
  • Macaya L; Center for Biotechnology and Biomedicine Spa, Concepción, Chile.
  • Neira P; Center for Biotechnology and Biomedicine Spa, Concepción, Chile.
  • Camacho F; Recombinant Biopharmaceuticals Laboratory, Pharmacology Department, School of Biological Sciences, Universidad de Concepción, Victor Lamas 1290, PO Box 160-C, Concepción, Chile.
  • González A; Recombinant Biopharmaceuticals Laboratory, Pharmacology Department, School of Biological Sciences, Universidad de Concepción, Victor Lamas 1290, PO Box 160-C, Concepción, Chile.
  • Acosta J; Recombinant Biopharmaceuticals Laboratory, Pharmacology Department, School of Biological Sciences, Universidad de Concepción, Victor Lamas 1290, PO Box 160-C, Concepción, Chile.
  • Montesino R; Biotechnology and Biopharmaceutical Laboratory, Pathophysiology Department, School of Biological Sciences, Universidad de Concepción, Victor Lamas 1290, PO Box 160-C, Concepción, Chile.
  • Toledo JR; Biotechnology and Biopharmaceutical Laboratory, Pathophysiology Department, School of Biological Sciences, Universidad de Concepción, Victor Lamas 1290, PO Box 160-C, Concepción, Chile.
  • Sánchez O; Center for Biotechnology and Biomedicine Spa, Concepción, Chile.
Biochem J ; 477(17): 3299-3311, 2020 09 18.
Article en En | MEDLINE | ID: mdl-32941643

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factor de Necrosis Tumoral alfa / Adalimumab / Etanercept Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factor de Necrosis Tumoral alfa / Adalimumab / Etanercept Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article